By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Paris      France
Phone: n/a Fax: n/a


Medical Device

Company News
Nanobiotix Announces First Positive Human Data Showing That NBTXR3 Could Become A Backbone In Immuno-Oncology 5/18/2017 11:02:36 AM
Nanobiotix: 2016 Annual Results 4/28/2017 11:10:38 AM
Nanobiotix Launches Capital Increase By Means Of An Accelerated Bookbuild Offering 4/7/2017 10:13:09 AM
Nanobiotix Bags EUR 25.1 Million Private Placement 4/7/2017 8:59:41 AM
Nanobiotix Expands Its Clinical Development In Head And Neck Cancer And I/O 4/4/2017 3:05:42 PM
Nanobiotix: The Independent Data Monitoring Committee Recommends The Continuation Of The Ongoing Phase II/IIITrial Of Nbtxr3 In Soft Tissue Sarcoma 3/23/2017 12:13:51 PM
Nanobiotix Appoints Senior Executive From Pharmaceutical Industry, As Chief Operating Officer 2/7/2017 12:15:30 PM
Nanobiotix: 2016 Review And 2017 Anticipated Milestones 2/2/2017 8:21:24 AM
Nanobiotix Reports Positive Phase I/II Preliminary Data On Feasibility And Safety Of NBTXR3 In Liver Cancers Trial 12/15/2016 9:40:28 AM
Nanobiotix Provides Update On Global Development Of Lead Product NBTXR3 11/28/2016 12:15:15 PM